People · Operator
Named in public records as an officer, director or promoter · active 2012–2012 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aastrom Biosciences Inc | — | Biotechnology | Series C | $40.0M | $1.6B | 2012 |
| Tosca Services, LLC | — | Other | Series B | $30.0M | $498.4M | 2012 |
Nelson M. Sims at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nelson M. Sims on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter W. Boylan | 1 | 6 |
| Timothy M. Mayleben | 1 | 4 |
| Alan L. Rubino | 1 | 3 |
| Phil D. Collins | 1 | 3 |
| John Frey | 1 | 2 |
| Ronald M. Cresswell | 1 | 2 |
| Robert L. Zerbe | 1 | 2 |
| Harold C. Urschel | 1 | 1 |
| Robert J. Kohlhepp | 1 | 1 |
| Michael J. Fechter | 1 | 1 |
| Robin J. Last | 1 | 1 |
| Jere E. Dhein | 1 | 1 |
| Brian D. Gibson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.